spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

SMi’s 5th Molecular Diagnostics Conference

9-11 July 2018
Holiday Inn Kensington Forum, London, UK

SMi is proud to announce their 5th Molecular Diagnostics conference. The event will take place in central London on Monday 9th and Tuesday 10th July 2018, along with two half-day post-conference workshops taking place on Wednesday 11th July 2018.

The global molecular diagnostics market is forecasted to reach over US$10 billion in the next three years, at a CAGR of 9.1% from 2016 to 2021*. In an ever-evolving universe of molecular diagnostics, it is vital to keep up with emerging and developing technology, products and applications. Furthermore, companies must comply to the constantly change regulatory environment and tackle the challenging process if implementing these regulations.

SMi welcomes you to explore the expanding market opportunities, the least diagnostics advancements and regulatory requirements at the 5th Molecular Diagnostics Conference.

This event is CPD accredited.

#SMiMolecularDx

Speaker Line-Up includes Matthew Albert, Nicholas Dale, Ana Alfirevic, Ashfaq Gilkar, Ben Courtney, Professor Kewal Jain, Matthew Albert, Miro Venturi.

Key themes for molecular diagnostics 2018:

  • Regulatory changes, challenges and outlook
  • Advances in laboratory technologies, including: biochips, nanotechnologies and proteomic technologies
  • Personalised medicine & pharmacogenomics
  • Diagnostic methods at the point of care
  • Molecular Diagnostics in Prenatal, Infectious Disease and Cancer

(*The Market Report can be found here: https://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html.)

Who should attend?

Attendees will primarily be drawn from the following backgrounds/departments:

Molecular Diagnostic, Cancer Immunology, Immunobiology, Biomarkers, Radiation Oncology, Therapeutic Radiology, Translational Medicine, Translational Assays Technologies, Companion Diagnostics, Clinical Chemistry, Experimental Medicine and Diagnostics.

They will include Leads, Directors, Heads, Project Managers, Principal Investigators, Principal Scientists, Senior Scientists, Research Scientist, Professors, Researchers and Clinical Analysts, amongst others.

 
Print this page
Send to a friend
   
spacer
Industry Events

INTERPHEX 2020

15-17 July 2020, Javits Center NYC


More info >>

White Papers

Crossing the Blood Brain Barrier (BBB): Which Route to Take?

Aptar Pharma

Aptar Pharma recently hosted an expert panel/roundtable on the various approaches to treating central nervous system (CNS) diseases. This international scientific forum was held in Paris, France on December 5th, 2014. The roundtable was organized to explore and exchange views on the challenges, approaches and opportunities that exist with regard to effectively crossing the blood brain barrier (BBB) and successfully treating a host of CNS diseases.
More info >>


News and Press Releases

Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed

Burgdorf – Teva Pharmaceutical Industries Ltd. (Teva), a global leader in generic medicines with innovative treatments in select areas, including central nervous system, pain and respiratory, launches its drug product AJOVY® in the pre-filled YpsoMate 2.25 autoinjector from Ypsomed. AJOVY® is used for the preventive treatment of migraine in adults. The collaboration with Teva marks the first commercial market entry of Ypsomed’s larger 2.25 ml autoinjector YpsoMate 2.25.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement